Global Carmustine Market Insights and Forecast to 2028

Global Carmustine Market Insights and Forecast to 2028

Table of Contents
1 Study Coverage
1.1 Carmustine Product Introduction
1.2 Market by Type
1.2.1 Global Carmustine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 100mg Injection
1.2.3 125mg Injection
1.3 Market by Application
1.3.1 Global Carmustine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Glioma
1.3.3 Glioblastoma Multiforme
1.3.4 Medulloblastoma and Astrocytoma
1.3.5 Multiple Myeloma
1.3.6 Lymphoma
1.3.7 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Carmustine Sales Estimates and Forecasts 2017-2028
2.2 Global Carmustine Revenue Estimates and Forecasts 2017-2028
2.3 Global Carmustine Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Carmustine Sales by Region
2.4.1 Global Carmustine Sales by Region (2017-2022)
2.4.2 Global Sales Carmustine by Region (2023-2028)
2.5 Global Carmustine Revenue by Region
2.5.1 Global Carmustine Revenue by Region (2017-2022)
2.5.2 Global Carmustine Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Carmustine Sales by Manufacturers
3.1.1 Global Top Carmustine Manufacturers by Sales (2017-2022)
3.1.2 Global Carmustine Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Carmustine in 2021
3.2 Global Carmustine Revenue by Manufacturers
3.2.1 Global Carmustine Revenue by Manufacturers (2017-2022)
3.2.2 Global Carmustine Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Carmustine Revenue in 2021
3.3 Global Carmustine Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Carmustine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Carmustine Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Carmustine Sales by Type
4.1.1 Global Carmustine Historical Sales by Type (2017-2022)
4.1.2 Global Carmustine Forecasted Sales by Type (2023-2028)
4.1.3 Global Carmustine Sales Market Share by Type (2017-2028)
4.2 Global Carmustine Revenue by Type
4.2.1 Global Carmustine Historical Revenue by Type (2017-2022)
4.2.2 Global Carmustine Forecasted Revenue by Type (2023-2028)
4.2.3 Global Carmustine Revenue Market Share by Type (2017-2028)
4.3 Global Carmustine Price by Type
4.3.1 Global Carmustine Price by Type (2017-2022)
4.3.2 Global Carmustine Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Carmustine Sales by Application
5.1.1 Global Carmustine Historical Sales by Application (2017-2022)
5.1.2 Global Carmustine Forecasted Sales by Application (2023-2028)
5.1.3 Global Carmustine Sales Market Share by Application (2017-2028)
5.2 Global Carmustine Revenue by Application
5.2.1 Global Carmustine Historical Revenue by Application (2017-2022)
5.2.2 Global Carmustine Forecasted Revenue by Application (2023-2028)
5.2.3 Global Carmustine Revenue Market Share by Application (2017-2028)
5.3 Global Carmustine Price by Application
5.3.1 Global Carmustine Price by Application (2017-2022)
5.3.2 Global Carmustine Price Forecast by Application (2023-2028)
6 North America
6.1 North America Carmustine Market Size by Type
6.1.1 North America Carmustine Sales by Type (2017-2028)
6.1.2 North America Carmustine Revenue by Type (2017-2028)
6.2 North America Carmustine Market Size by Application
6.2.1 North America Carmustine Sales by Application (2017-2028)
6.2.2 North America Carmustine Revenue by Application (2017-2028)
6.3 North America Carmustine Market Size by Country
6.3.1 North America Carmustine Sales by Country (2017-2028)
6.3.2 North America Carmustine Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Carmustine Market Size by Type
7.1.1 Europe Carmustine Sales by Type (2017-2028)
7.1.2 Europe Carmustine Revenue by Type (2017-2028)
7.2 Europe Carmustine Market Size by Application
7.2.1 Europe Carmustine Sales by Application (2017-2028)
7.2.2 Europe Carmustine Revenue by Application (2017-2028)
7.3 Europe Carmustine Market Size by Country
7.3.1 Europe Carmustine Sales by Country (2017-2028)
7.3.2 Europe Carmustine Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Carmustine Market Size by Type
8.1.1 Asia Pacific Carmustine Sales by Type (2017-2028)
8.1.2 Asia Pacific Carmustine Revenue by Type (2017-2028)
8.2 Asia Pacific Carmustine Market Size by Application
8.2.1 Asia Pacific Carmustine Sales by Application (2017-2028)
8.2.2 Asia Pacific Carmustine Revenue by Application (2017-2028)
8.3 Asia Pacific Carmustine Market Size by Region
8.3.1 Asia Pacific Carmustine Sales by Region (2017-2028)
8.3.2 Asia Pacific Carmustine Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Carmustine Market Size by Type
9.1.1 Latin America Carmustine Sales by Type (2017-2028)
9.1.2 Latin America Carmustine Revenue by Type (2017-2028)
9.2 Latin America Carmustine Market Size by Application
9.2.1 Latin America Carmustine Sales by Application (2017-2028)
9.2.2 Latin America Carmustine Revenue by Application (2017-2028)
9.3 Latin America Carmustine Market Size by Country
9.3.1 Latin America Carmustine Sales by Country (2017-2028)
9.3.2 Latin America Carmustine Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Carmustine Market Size by Type
10.1.1 Middle East and Africa Carmustine Sales by Type (2017-2028)
10.1.2 Middle East and Africa Carmustine Revenue by Type (2017-2028)
10.2 Middle East and Africa Carmustine Market Size by Application
10.2.1 Middle East and Africa Carmustine Sales by Application (2017-2028)
10.2.2 Middle East and Africa Carmustine Revenue by Application (2017-2028)
10.3 Middle East and Africa Carmustine Market Size by Country
10.3.1 Middle East and Africa Carmustine Sales by Country (2017-2028)
10.3.2 Middle East and Africa Carmustine Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Amneal Pharms
11.1.1 Amneal Pharms Corporation Information
11.1.2 Amneal Pharms Overview
11.1.3 Amneal Pharms Carmustine Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Amneal Pharms Carmustine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Amneal Pharms Recent Developments
11.2 Arbor Pharms
11.2.1 Arbor Pharms Corporation Information
11.2.2 Arbor Pharms Overview
11.2.3 Arbor Pharms Carmustine Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Arbor Pharms Carmustine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Arbor Pharms Recent Developments
11.3 Emcure Pharms
11.3.1 Emcure Pharms Corporation Information
11.3.2 Emcure Pharms Overview
11.3.3 Emcure Pharms Carmustine Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Emcure Pharms Carmustine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Emcure Pharms Recent Developments
11.4 Navinta
11.4.1 Navinta Corporation Information
11.4.2 Navinta Overview
11.4.3 Navinta Carmustine Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Navinta Carmustine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Navinta Recent Developments
11.5 STI Pharma
11.5.1 STI Pharma Corporation Information
11.5.2 STI Pharma Overview
11.5.3 STI Pharma Carmustine Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 STI Pharma Carmustine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 STI Pharma Recent Developments
11.6 Obvius Pharmaceuticals
11.6.1 Obvius Pharmaceuticals Corporation Information
11.6.2 Obvius Pharmaceuticals Overview
11.6.3 Obvius Pharmaceuticals Carmustine Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Obvius Pharmaceuticals Carmustine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Obvius Pharmaceuticals Recent Developments
11.7 MGI Pharma
11.7.1 MGI Pharma Corporation Information
11.7.2 MGI Pharma Overview
11.7.3 MGI Pharma Carmustine Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 MGI Pharma Carmustine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 MGI Pharma Recent Developments
11.8 Marcan Pharmaceuticals
11.8.1 Marcan Pharmaceuticals Corporation Information
11.8.2 Marcan Pharmaceuticals Overview
11.8.3 Marcan Pharmaceuticals Carmustine Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Marcan Pharmaceuticals Carmustine Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Marcan Pharmaceuticals Recent Developments
11.9 Eisai
11.9.1 Eisai Corporation Information
11.9.2 Eisai Overview
11.9.3 Eisai Carmustine Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Eisai Carmustine Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Eisai Recent Developments
11.10 Bristol-Myers Squibb
11.10.1 Bristol-Myers Squibb Corporation Information
11.10.2 Bristol-Myers Squibb Overview
11.10.3 Bristol-Myers Squibb Carmustine Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Bristol-Myers Squibb Carmustine Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Bristol-Myers Squibb Recent Developments
11.11 Pharmaplan
11.11.1 Pharmaplan Corporation Information
11.11.2 Pharmaplan Overview
11.11.3 Pharmaplan Carmustine Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Pharmaplan Carmustine Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Pharmaplan Recent Developments
11.12 Sanli Ilac
11.12.1 Sanli Ilac Corporation Information
11.12.2 Sanli Ilac Overview
11.12.3 Sanli Ilac Carmustine Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Sanli Ilac Carmustine Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Sanli Ilac Recent Developments
11.13 Zydus Pharmaceuticals 
11.13.1 Zydus Pharmaceuticals  Corporation Information
11.13.2 Zydus Pharmaceuticals  Overview
11.13.3 Zydus Pharmaceuticals  Carmustine Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Zydus Pharmaceuticals  Carmustine Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Zydus Pharmaceuticals  Recent Developments
11.14 Tianjin Kingyork
11.14.1 Tianjin Kingyork Corporation Information
11.14.2 Tianjin Kingyork Overview
11.14.3 Tianjin Kingyork Carmustine Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Tianjin Kingyork Carmustine Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Tianjin Kingyork Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Carmustine Industry Chain Analysis
12.2 Carmustine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Carmustine Production Mode & Process
12.4 Carmustine Sales and Marketing
12.4.1 Carmustine Sales Channels
12.4.2 Carmustine Distributors
12.5 Carmustine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Carmustine Industry Trends
13.2 Carmustine Market Drivers
13.3 Carmustine Market Challenges
13.4 Carmustine Market Restraints
14 Key Findings in The Global Carmustine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Carmustine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of 100mg Injection
Table 3. Major Manufacturers of 125mg Injection
Table 4. Global Carmustine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Carmustine Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Carmustine Sales by Region (2017-2022) & (K Pcs)
Table 7. Global Carmustine Sales Market Share by Region (2017-2022)
Table 8. Global Carmustine Sales by Region (2023-2028) & (K Pcs)
Table 9. Global Carmustine Sales Market Share by Region (2023-2028)
Table 10. Global Carmustine Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Carmustine Revenue Market Share by Region (2017-2022)
Table 12. Global Carmustine Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Carmustine Revenue Market Share by Region (2023-2028)
Table 14. Global Carmustine Sales by Manufacturers (2017-2022) & (K Pcs)
Table 15. Global Carmustine Sales Share by Manufacturers (2017-2022)
Table 16. Global Carmustine Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Carmustine Revenue Share by Manufacturers (2017-2022)
Table 18. Carmustine Price by Manufacturers (2017-2022) &(USD/Pcs)
Table 19. Global Carmustine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Carmustine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Carmustine as of 2021)
Table 21. Carmustine Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Carmustine Product Offered
Table 23. Date of Manufacturers Enter into Carmustine Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Carmustine Sales by Type (2017-2022) & (K Pcs)
Table 26. Global Carmustine Sales by Type (2023-2028) & (K Pcs)
Table 27. Global Carmustine Sales Share by Type (2017-2022)
Table 28. Global Carmustine Sales Share by Type (2023-2028)
Table 29. Global Carmustine Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Carmustine Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Carmustine Revenue Share by Type (2017-2022)
Table 32. Global Carmustine Revenue Share by Type (2023-2028)
Table 33. Carmustine Price by Type (2017-2022) & (USD/Pcs)
Table 34. Global Carmustine Price Forecast by Type (2023-2028) & (USD/Pcs)
Table 35. Global Carmustine Sales by Application (2017-2022) & (K Pcs)
Table 36. Global Carmustine Sales by Application (2023-2028) & (K Pcs)
Table 37. Global Carmustine Sales Share by Application (2017-2022)
Table 38. Global Carmustine Sales Share by Application (2023-2028)
Table 39. Global Carmustine Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Carmustine Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Carmustine Revenue Share by Application (2017-2022)
Table 42. Global Carmustine Revenue Share by Application (2023-2028)
Table 43. Carmustine Price by Application (2017-2022) & (USD/Pcs)
Table 44. Global Carmustine Price Forecast by Application (2023-2028) & (USD/Pcs)
Table 45. North America Carmustine Sales by Type (2017-2022) & (K Pcs)
Table 46. North America Carmustine Sales by Type (2023-2028) & (K Pcs)
Table 47. North America Carmustine Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Carmustine Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Carmustine Sales by Application (2017-2022) & (K Pcs)
Table 50. North America Carmustine Sales by Application (2023-2028) & (K Pcs)
Table 51. North America Carmustine Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Carmustine Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Carmustine Sales by Country (2017-2022) & (K Pcs)
Table 54. North America Carmustine Sales by Country (2023-2028) & (K Pcs)
Table 55. North America Carmustine Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Carmustine Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Carmustine Sales by Type (2017-2022) & (K Pcs)
Table 58. Europe Carmustine Sales by Type (2023-2028) & (K Pcs)
Table 59. Europe Carmustine Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Carmustine Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Carmustine Sales by Application (2017-2022) & (K Pcs)
Table 62. Europe Carmustine Sales by Application (2023-2028) & (K Pcs)
Table 63. Europe Carmustine Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Carmustine Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Carmustine Sales by Country (2017-2022) & (K Pcs)
Table 66. Europe Carmustine Sales by Country (2023-2028) & (K Pcs)
Table 67. Europe Carmustine Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Carmustine Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Carmustine Sales by Type (2017-2022) & (K Pcs)
Table 70. Asia Pacific Carmustine Sales by Type (2023-2028) & (K Pcs)
Table 71. Asia Pacific Carmustine Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Carmustine Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Carmustine Sales by Application (2017-2022) & (K Pcs)
Table 74. Asia Pacific Carmustine Sales by Application (2023-2028) & (K Pcs)
Table 75. Asia Pacific Carmustine Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Carmustine Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Carmustine Sales by Region (2017-2022) & (K Pcs)
Table 78. Asia Pacific Carmustine Sales by Region (2023-2028) & (K Pcs)
Table 79. Asia Pacific Carmustine Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Carmustine Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Carmustine Sales by Type (2017-2022) & (K Pcs)
Table 82. Latin America Carmustine Sales by Type (2023-2028) & (K Pcs)
Table 83. Latin America Carmustine Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Carmustine Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Carmustine Sales by Application (2017-2022) & (K Pcs)
Table 86. Latin America Carmustine Sales by Application (2023-2028) & (K Pcs)
Table 87. Latin America Carmustine Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Carmustine Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Carmustine Sales by Country (2017-2022) & (K Pcs)
Table 90. Latin America Carmustine Sales by Country (2023-2028) & (K Pcs)
Table 91. Latin America Carmustine Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Carmustine Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Carmustine Sales by Type (2017-2022) & (K Pcs)
Table 94. Middle East and Africa Carmustine Sales by Type (2023-2028) & (K Pcs)
Table 95. Middle East and Africa Carmustine Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Carmustine Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Carmustine Sales by Application (2017-2022) & (K Pcs)
Table 98. Middle East and Africa Carmustine Sales by Application (2023-2028) & (K Pcs)
Table 99. Middle East and Africa Carmustine Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Carmustine Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Carmustine Sales by Country (2017-2022) & (K Pcs)
Table 102. Middle East and Africa Carmustine Sales by Country (2023-2028) & (K Pcs)
Table 103. Middle East and Africa Carmustine Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Carmustine Revenue by Country (2023-2028) & (US$ Million)
Table 105. Amneal Pharms Corporation Information
Table 106. Amneal Pharms Description and Major Businesses
Table 107. Amneal Pharms Carmustine Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 108. Amneal Pharms Carmustine Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Amneal Pharms Recent Developments
Table 110. Arbor Pharms Corporation Information
Table 111. Arbor Pharms Description and Major Businesses
Table 112. Arbor Pharms Carmustine Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 113. Arbor Pharms Carmustine Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Arbor Pharms Recent Developments
Table 115. Emcure Pharms Corporation Information
Table 116. Emcure Pharms Description and Major Businesses
Table 117. Emcure Pharms Carmustine Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 118. Emcure Pharms Carmustine Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Emcure Pharms Recent Developments
Table 120. Navinta Corporation Information
Table 121. Navinta Description and Major Businesses
Table 122. Navinta Carmustine Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 123. Navinta Carmustine Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Navinta Recent Developments
Table 125. STI Pharma Corporation Information
Table 126. STI Pharma Description and Major Businesses
Table 127. STI Pharma Carmustine Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 128. STI Pharma Carmustine Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. STI Pharma Recent Developments
Table 130. Obvius Pharmaceuticals Corporation Information
Table 131. Obvius Pharmaceuticals Description and Major Businesses
Table 132. Obvius Pharmaceuticals Carmustine Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 133. Obvius Pharmaceuticals Carmustine Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Obvius Pharmaceuticals Recent Developments
Table 135. MGI Pharma Corporation Information
Table 136. MGI Pharma Description and Major Businesses
Table 137. MGI Pharma Carmustine Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 138. MGI Pharma Carmustine Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. MGI Pharma Recent Developments
Table 140. Marcan Pharmaceuticals Corporation Information
Table 141. Marcan Pharmaceuticals Description and Major Businesses
Table 142. Marcan Pharmaceuticals Carmustine Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 143. Marcan Pharmaceuticals Carmustine Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Marcan Pharmaceuticals Recent Developments
Table 145. Eisai Corporation Information
Table 146. Eisai Description and Major Businesses
Table 147. Eisai Carmustine Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 148. Eisai Carmustine Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Eisai Recent Developments
Table 150. Bristol-Myers Squibb Corporation Information
Table 151. Bristol-Myers Squibb Description and Major Businesses
Table 152. Bristol-Myers Squibb Carmustine Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 153. Bristol-Myers Squibb Carmustine Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Bristol-Myers Squibb Recent Developments
Table 155. Pharmaplan Corporation Information
Table 156. Pharmaplan Description and Major Businesses
Table 157. Pharmaplan Carmustine Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 158. Pharmaplan Carmustine Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. Pharmaplan Recent Developments
Table 160. Sanli Ilac Corporation Information
Table 161. Sanli Ilac Description and Major Businesses
Table 162. Sanli Ilac Carmustine Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 163. Sanli Ilac Carmustine Product Model Numbers, Pictures, Descriptions and Specifications
Table 164. Sanli Ilac Recent Developments
Table 165. Zydus Pharmaceuticals  Corporation Information
Table 166. Zydus Pharmaceuticals  Description and Major Businesses
Table 167. Zydus Pharmaceuticals  Carmustine Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 168. Zydus Pharmaceuticals  Carmustine Product Model Numbers, Pictures, Descriptions and Specifications
Table 169. Zydus Pharmaceuticals  Recent Developments
Table 170. Tianjin Kingyork Corporation Information
Table 171. Tianjin Kingyork Description and Major Businesses
Table 172. Tianjin Kingyork Carmustine Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 173. Tianjin Kingyork Carmustine Product Model Numbers, Pictures, Descriptions and Specifications
Table 174. Tianjin Kingyork Recent Developments
Table 175. Key Raw Materials Lists
Table 176. Raw Materials Key Suppliers Lists
Table 177. Carmustine Distributors List
Table 178. Carmustine Customers List
Table 179. Carmustine Market Trends
Table 180. Carmustine Market Drivers
Table 181. Carmustine Market Challenges
Table 182. Carmustine Market Restraints
Table 183. Research Programs/Design for This Report
Table 184. Key Data Information from Secondary Sources
Table 185. Key Data Information from Primary Sources
List of Figures
Figure 1. Carmustine Product Picture
Figure 3. Global Carmustine Market Share by Type in 2021 & 2028
Figure 3. 100mg Injection Product Picture
Figure 4. 125mg Injection Product Picture
Figure 5. Global Carmustine Market Share by Application in 2021 & 2028
Figure 6. Glioma
Figure 7. Glioblastoma Multiforme
Figure 8. Medulloblastoma and Astrocytoma
Figure 9. Multiple Myeloma
Figure 10. Lymphoma
Figure 11. Other
Figure 12. Carmustine Report Years Considered
Figure 13. Global Carmustine Sales 2017-2028 (K Pcs)
Figure 14. Global Carmustine Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global Carmustine Revenue 2017-2028 (US$ Million)
Figure 16. Global Carmustine Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 17. Global Carmustine Sales Market Share by Region (2017-2022)
Figure 18. Global Carmustine Sales Market Share by Region (2023-2028)
Figure 19. North America Carmustine Sales YoY (2017-2028) & (K Pcs)
Figure 20. North America Carmustine Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Europe Carmustine Sales YoY (2017-2028) & (K Pcs)
Figure 22. Europe Carmustine Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Asia-Pacific Carmustine Sales YoY (2017-2028) & (K Pcs)
Figure 24. Asia-Pacific Carmustine Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Latin America Carmustine Sales YoY (2017-2028) & (K Pcs)
Figure 26. Latin America Carmustine Revenue YoY (2017-2028) & (US$ Million)
Figure 27. Middle East & Africa Carmustine Sales YoY (2017-2028) & (K Pcs)
Figure 28. Middle East & Africa Carmustine Revenue YoY (2017-2028) & (US$ Million)
Figure 29. The Carmustine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 30. The Top 5 and 10 Largest Manufacturers of Carmustine in the World: Market Share by Carmustine Revenue in 2021
Figure 31. Global Carmustine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 32. Global Carmustine Sales Market Share by Type (2017-2028)
Figure 33. Global Carmustine Revenue Market Share by Type (2017-2028)
Figure 34. Global Carmustine Sales Market Share by Application (2017-2028)
Figure 35. Global Carmustine Revenue Market Share by Application (2017-2028)
Figure 36. North America Carmustine Sales Market Share by Type (2017-2028)
Figure 37. North America Carmustine Revenue Market Share by Type (2017-2028)
Figure 38. North America Carmustine Sales Market Share by Application (2017-2028)
Figure 39. North America Carmustine Revenue Market Share by Application (2017-2028)
Figure 40. North America Carmustine Sales Share by Country (2017-2028)
Figure 41. North America Carmustine Revenue Share by Country (2017-2028)
Figure 42. U.S. Carmustine Revenue (2017-2028) & (US$ Million)
Figure 43. Canada Carmustine Revenue (2017-2028) & (US$ Million)
Figure 44. Europe Carmustine Sales Market Share by Type (2017-2028)
Figure 45. Europe Carmustine Revenue Market Share by Type (2017-2028)
Figure 46. Europe Carmustine Sales Market Share by Application (2017-2028)
Figure 47. Europe Carmustine Revenue Market Share by Application (2017-2028)
Figure 48. Europe Carmustine Sales Share by Country (2017-2028)
Figure 49. Europe Carmustine Revenue Share by Country (2017-2028)
Figure 50. Germany Carmustine Revenue (2017-2028) & (US$ Million)
Figure 51. France Carmustine Revenue (2017-2028) & (US$ Million)
Figure 52. U.K. Carmustine Revenue (2017-2028) & (US$ Million)
Figure 53. Italy Carmustine Revenue (2017-2028) & (US$ Million)
Figure 54. Russia Carmustine Revenue (2017-2028) & (US$ Million)
Figure 55. Asia Pacific Carmustine Sales Market Share by Type (2017-2028)
Figure 56. Asia Pacific Carmustine Revenue Market Share by Type (2017-2028)
Figure 57. Asia Pacific Carmustine Sales Market Share by Application (2017-2028)
Figure 58. Asia Pacific Carmustine Revenue Market Share by Application (2017-2028)
Figure 59. Asia Pacific Carmustine Sales Share by Region (2017-2028)
Figure 60. Asia Pacific Carmustine Revenue Share by Region (2017-2028)
Figure 61. China Carmustine Revenue (2017-2028) & (US$ Million)
Figure 62. Japan Carmustine Revenue (2017-2028) & (US$ Million)
Figure 63. South Korea Carmustine Revenue (2017-2028) & (US$ Million)
Figure 64. India Carmustine Revenue (2017-2028) & (US$ Million)
Figure 65. Australia Carmustine Revenue (2017-2028) & (US$ Million)
Figure 66. Taiwan Carmustine Revenue (2017-2028) & (US$ Million)
Figure 67. Indonesia Carmustine Revenue (2017-2028) & (US$ Million)
Figure 68. Thailand Carmustine Reven

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global 5-Fluorouracil Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 76

The global 5-Fluorouracil market was valued at US$ 283 million in 2023 and is anticipated to reach US$ 487.9 million by 2030, witnessing a CAGR of 4.3% during The forecast period 2024-2030. North American market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by ......

Global Carboplatin Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global Carboplatin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % d......

Global Neutropenia Drugs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 96

The global Neutropenia Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated to increa......

Global Small Molecule Cancer Drug Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Small Molecule Cancer Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated ......

Global Capecitabine Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 80

Capecitabine is an orally-administered chemotherapeutic agent used in The treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in The tumor, where it inhibits DNA synthesis and slows growth of tumor tissue. Common side effects include abdominal pain, vomiting, diarrhea, weakness, and rashes. Other severe side effects include blood clotting problems, allergic reactions, heart problems, and low blo......

Global Oxaliplatin Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 104

Oxaliplatin is a platinum-based anticancer drug with colorless or nearly colorless transparent liquid. It is often used for metastatic colorectal cancer treatment or adjuvant therapy The third stage colon cancer after resecting primary tumor completely. In this report, only The finished drug is covered, exclude API. The global Oxaliplatin market was valued at US$ 897.5 million in 2023 and is anticipated to reach US$ 1641.5 million by 2030, witnessing a CAGR of 8.9% duri......

Global Cancer Treatment Drugs Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 158

According to our LPI (LP Information) latest study, the global Cancer Treatment Drugs market size was valued at US$ 174990 million in 2023. With growing demand in downstream market, the Cancer Treatment Drugs is forecast to a readjusted size of US$ 322540 million by 2030 with a CAGR of 9.1% during review period. The research report highlights the growth potential of the global Cancer Treatment Drugs market. Cancer Treatment Drugs are expected to show stable growth in the future market. H......

Global Capecitabine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 93

According to our LPI (LP Information) latest study, the global Capecitabine market size was valued at US$ 1003.9 million in 2023. With growing demand in downstream market, the Capecitabine is forecast to a readjusted size of US$ 975.1 million by 2030 with a CAGR of -0.4% during review period. The research report highlights the growth potential of the global Capecitabine market. Capecitabine are expected to show stable growth in the future market. However, product differentiation, reducin......

Global Methotrexate Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95

According to our LPI (LP Information) latest study, the global Methotrexate market size was valued at US$ 506 million in 2023. With growing demand in downstream market, the Methotrexate is forecast to a readjusted size of US$ 613.9 million by 2030 with a CAGR of 2.8% during review period. The research report highlights the growth potential of the global Methotrexate market. Methotrexate are expected to show stable growth in the future market. However, product differentiation, reducing co......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs